Articles

• Wang W, Chen S, Brune KA, Hruban RH, Parmigiani G, Klein AP. Development and Validation of a Risk Assessment Tool for Individuals with a Family History of Pancreatic Cancer: PancPRO. Journal of Clinical Oncology To appear
• Chen S, Wang W, Lee S, Nafa K, Lee J,Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor N, Casey G, Ellis N, Giardiello FM, {the Colon Cancer Family Registry},Offit K, Parmigiani G. Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome. Journal of the American Medical Association. September 27, 2006; 296(12): 1479-1487. [Abstract] [Full text] [PDF]
• Gonzalez JR, Wang W, Ballana E and Estivill X. A recessive Mendelian model to predict carrier probabilities of DFNB1 for non-Syndromic deafness. Human Mutation. 2006; DOI 10.1002/humu.20390. [Abstract] [PDF]
• Chen S, Wang W, Broman K and Parmigiani G. BayesMendel: An R Environment for Mendelian Risk Prediction. Statistical Application in Genetics and Molecular Biology. 3(1): Article 21, 2004. [Abstract] [PDF]
• Xu Z, Sproul A, Wang W, Kukekov N, and Greene LA. Siah1 Interacts with the Scaffold Protein POSH to Promote JNK Activation and Apoptosis. Journal of Biological Chemistry Vol. 281, Issue 1, 303-312, January 6, 2006. [Abstract] [Full text] [PDF]
• Ge XC, Chen JC, Wang WY, Cao KM, Sun CR. [Construction of the mutants of rice nonspecific lipid transfer protein and expression comparison in two kinds of thioredoxin fusion expression vectors]. Sheng Wu Gong Cheng Xue Bao. 18(2): 167-71, 2002. Chinese [Abstract]

Proceedings

• Wang W, Carvalho B, Miller N, Pevsner J, Chakaravarti A and Irizarry RA. Estimating Genome-wide Copy Number using Allele Specific Mixture Models. Lecture Notes in Bioinformatics (Springer Verlag), RECOMB2007. To appear [Extended Abstract]

Articles nearing completion

• Wang W, Klein AP, Caffo B and Parmigiani G. Validating risk prediction models using family registries.
• Wang W, Niendorf KB, Patel D, Marroni F, Parmigiani G and Tsao H. Predicting Germline p16 Mutational Status within Melanoma Families using MELAPRO.

                                                                                   Back to Home Page